Skip to main content
Caplight Logo









Ceriter

Ceriter

Private
LanakenHealthcare & Life Scienceshttps://www.ceriter.com/

Last Round

Accelerator

Jul 7, 2022

Total Funding Raised

$51,000

Company Overview

Ceriter operates in Healthcare & Life Sciences and is based in Lanaken. Its latest recorded funding round was an Accelerator round in July 2022.

Ceriter is a medical technology company that develops Stride One, a smart gait rehabilitation platform featuring sensor-equipped insoles and a mobile app to provide real-time biofeedback and remote monitoring for patients and therapists.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ceriter Comparables

Compare Ceriter with similar companies based on industry and business-model similarity.

Ceriter comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
stAPPtronics
92%
Magnes AG
86%
Dynamic Metrics Limited
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ceriter Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 7, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Ceriter Investors

Notable investors and investment history

Ceriter investors
InvestorRounds
imec.istartAccelerator
LIOFGrant, Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 98% MoM, reaching 2.7K.

  • Feb 25, 2025

    Grew 75% QoQ, from 4 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ceriter Filings

Explore SEC and related filing metadata, where available.

Ceriter filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ceriter's valuation, stock price, and market status.

Is Ceriter a public or private company?

Ceriter is a private company.

What is the current stock price of Ceriter?

Ceriter is a private company, so its shares have no public market price. Caplight tracks Ceriter's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ceriter worth (valuation)?

Valuation information for Ceriter is not publicly available.

Can I buy Ceriter stock?

Ceriter shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ceriter's last funding round?

Ceriter's most recent funding round was Accelerator on July 7, 2022.

Who are the main investors in Ceriter?

Key investors in Ceriter include imec.istart, LIOF.

Will Ceriter IPO soon?

No public IPO plans have been announced for Ceriter.

How can I track Ceriter secondary market activity?

Caplight tracks bids, offers, and trades in Ceriter's shares on secondary markets.

Firmographic Details

HeadquartersLanaken
Employee Range7
Year Founded2020
Last FundingJul 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?